Tag Archives: RxEvolution

Elixir Launches a Specialty Generic Program

Elixir, a wholly owned subsidiary of Rite Aid, recently announced the launch of a specialty generic medication enhancement to its managed copay solutions effective June 1, 2022

Rite Aid’s Disappointing PBM Q3 2021 Results Leads to Rebate Aggregation Agreement with Prime Therapeutics

Rite Aid is implementing a number of strategies to make up Q3 2021 PBM revenue shortfall, including closing 63 stores and improving PBM margins from its new rebate aggregation agreement with Prime Therapeutics